Grants and Contributions:
Title:
Critical technology transfer activities to enable timely and cost effective adeno-associated virus (AAV) biomanufacturing at the Biotherapeutics Manaufacturing Centre
Agreement Number:
992639
Agreement Value:
$637,634.00
Agreement Date:
Jul 20, 2022 - Feb 20, 2025
Description:
This project will support process and assay development efforts currently ongoing at the NRC for an adeno-associated virus (AAV)-based next generation LPLD gene therapy. The goal of this project will be to accelerate the rate at which this therapy is GMP manufactured and subsequently ready to be tested in the clinic, by formally combining the efforts, experience and expertise of both the NRC and BMC-VMF to finalize process parameters and develop and qualify key GMP release tests that will be executed at the BMC.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Ottawa, Ontario, CA K1Y 4E9
Reference Number:
172-2021-2022-Q2-992466
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
886822212
Recipient Type:
Not-for-profit organization or charity
Additional Information:
This agreement has been amended 4 time(s). The end date of this agreement has been modified by 82 days.
Amendment Date
Nov 25, 2024
Recipient's Legal Name:
Ottawa Hospital Research Institute
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35079
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710
Amendments: